Company Name: Clearside Biomedical, Inc.
Clearside Biomedical, Inc. is a late stage clinical biopharmaceutical company. The company is engaged in the development of therapies for blinding eye diseases. The company’s developmental pipeline includes product candidates for:
- Macular edema associated with non-infectious uveitis
- Macular edema associated with retinal vein occlusion
- Wet age-related macular degeneration
Ticker Symbol: CLSD (NASDAQ)
Company Website: http://clearsidebio.com
Headquarters: Alpharetta, GA